enrofloxacin has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, M; Li, H; Li, W; Pan, X; Shan, L; Tian, H; Wang, J | 1 |
| Guo, LH; Lei, Y; Li, F; Li, M; Li, Z; Mortimer, M; Peng, BX; Zhuang, G | 1 |
2 other study(ies) available for enrofloxacin and Obesity
| Article | Year |
|---|---|
Association between fluoroquinolone exposure and children's growth and development: A multisite biomonitoring-based study in northern China.
Topics: Animals; Anti-Bacterial Agents; Biological Monitoring; Child; China; Ciprofloxacin; Enrofloxacin; Fleroxacin; Fluoroquinolones; Humans; Obesity; Ofloxacin; Overweight | 2022 |
Antibiotics disrupt lipid metabolism in zebrafish (Danio rerio) larvae and 3T3-L1 preadipocytes.
Topics: 3T3-L1 Cells; Animals; Anti-Bacterial Agents; Doxycycline; Enrofloxacin; Larva; Lipid Metabolism; Mice; Obesity; PPAR gamma; Triglycerides; Zebrafish | 2023 |